Euro vs US Dollar

Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.

Registrieren

GRTX Galera Therapeutics Inc

0,145

0,00 (0,00%)

15 Jan 2025 - Geschlossen

Verzögert um 15 Minuten

Form 3 - Initial statement of beneficial ownership of securities

Galera Therapeutics (NASDAQ:GRTX)
Historical Stock Chart
Von Dez 2024 bis Jan 2025

Click Here for more Galera Therapeutics Charts.

Galera Therapeutics (NASDAQ:GRTX)
Historical Stock Chart
Von Jan 2024 bis Jan 2025

Click Here for more Galera Therapeutics Charts.

News Galera Therapeutics Inc

Galera Therapeutics completes acquisition of Nova Pharmaceuticals
Dienstag 31 Dezember 2024 (2 Wochen vor) • GlobeNewswire Inc.

Form PRE 14A - Other preliminary proxy statements
Freitag 23 August 2024 (5 Monate vor) • Edgar (US Regulatory)

Galera Announces Board Approval of Complete Liquidation and Dissolution
Mittwoch 14 August 2024 (5 Monate vor) • GlobeNewswire Inc.

Form 8-K - Current report
Freitag 7 Juni 2024 (7 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Montag 3 Juni 2024 (7 Monate vor) • Edgar (US Regulatory)

Form 3 - Initial statement of beneficial ownership of securities
Donnerstag 16 Mai 2024 (8 Monate vor) • Edgar (US Regulatory)

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Donnerstag 16 Mai 2024 (8 Monate vor) • Edgar (US Regulatory)

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Donnerstag 16 Mai 2024 (8 Monate vor) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Montag 13 Mai 2024 (8 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Montag 13 Mai 2024 (8 Monate vor) • Edgar (US Regulatory)

Galera Reports First Quarter 2024 Financial Results and Recent Corporate Updates
Montag 13 Mai 2024 (8 Monate vor) • GlobeNewswire Inc.

Galera Adopts Limited Duration Stockholder Rights Agreement
Freitag 3 Mai 2024 (8 Monate vor) • GlobeNewswire Inc.

Weitere Galera Therapeutics Inc News-Artikel

F&c Private Equity Trust

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen